Björntorp P, Carlgren G, Isaksson B, Krotkiewski M, Larsson B, Sjöström L
Am J Clin Nutr. 1975 May;28(5):445-52. doi: 10.1093/ajcn/28.5.445.
Twenty-eight obese women were divided after arbitrary statistical guidelines obtained from control studies into hyperplastic (increase in fat cell number) (n equal to 10), hypertrophic obesity (increase in average fat cell size) (n equal to 11), and a remaining group (n equal to 7). All these subjects were treated on an outpatient basis with an energy-reduced diet (1,100 kcal/day) until weight decrease failure occurred. The fat cells of the femoral and gluteal regions were larger than in the abdominal region in hypertrophic obese subjects. This regional fat cell size profile was found also in middle-aged and young controls. The hyperplastic obese subjects on the other hand had larger fat cells in the abdominal site. At failure of therapy enlarged fat cells in either of the two obesity groups had decreased to the size of fat cells of controls. Fat cell number remained unchanged. Thus the hypertrophic obese patients ended up with a normal body fat while hyperplastic obese subjects had a pronounced remaining obesity. The results suggest that when the fat cell size in different regions of an individual are known, as well as the total fat cell number, the success of an energy-reduced dietary regimen might be approximately predicted both in terms of remaining total body fat and in regional fat depot decrease.
根据对照研究得出的任意统计准则,将28名肥胖女性分为增生性肥胖(脂肪细胞数量增加)组(n = 10)、肥大性肥胖(平均脂肪细胞大小增加)组(n = 11)和其余一组(n = 7)。所有这些受试者均在门诊接受低能量饮食治疗(1100千卡/天),直至体重减轻失败。在肥大性肥胖受试者中,股骨和臀部区域的脂肪细胞比腹部区域的大。在中年和年轻对照组中也发现了这种区域性脂肪细胞大小分布情况。另一方面,增生性肥胖受试者腹部的脂肪细胞更大。治疗失败时,两个肥胖组中增大的脂肪细胞均已缩小至对照组脂肪细胞的大小。脂肪细胞数量保持不变。因此,肥大性肥胖患者最终拥有正常的体脂,而增生性肥胖受试者则有明显的残余肥胖。结果表明,当了解个体不同区域的脂肪细胞大小以及脂肪细胞总数时,就剩余的全身脂肪和区域性脂肪储存减少而言,低能量饮食方案的成功与否可能大致可以预测。